QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Releases First-Quarter 2022 Financial Report, Corporate Update
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and specialty services to the worldwide biopharmaceuticals, cosmetics, nutraceuticals, agrochem, and food & beverage industries, is reporting its financial results for Q1 2022, the period ended March 31, 2022; the company also released a business update provided guidance for the remainder of the year. Key numbers from the report include total revenue for the quarter totaling $480,000, down 14% from $560,000 for Q1 2021; instrument sales of $465,000, compared to $553,800 for Q1 2021; and consumable sales for the quarter reached $40,000,…